Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:29:49 EDT Wed 09 Oct 2024
Enter Symbol
or Name
USA
CA



News for U:GRCL from 2023-10-10 to 2024-10-09 - 15 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-02-22 08:45U:GRCLNews ReleaseGracell Biotechnologies Acquisition Completed
2024-02-20 07:45U:GRCLNews ReleaseGracell Biotechnologies Announces Shareholders ¢ € ™ Approval of Merger Agreement
2024-01-29 07:00U:GRCLNews ReleaseGracell Biotechnologies Announces FDA Clearance of IND Application ‚  for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment ‚  of Multiple Myeloma
2023-12-26 02:01U:GRCLNews ReleaseAstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
2023-12-26 02:00U:GRCLNews ReleaseGracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases
2023-12-21 07:00U:GRCLNews ReleaseGracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
2023-12-11 19:30U:GRCLNews ReleaseGracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023
2023-11-27 08:00U:GRCLNews ReleaseGracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus
2023-11-16 08:00U:GRCLNews ReleaseGracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit
2023-11-13 07:30U:GRCLNews ReleaseGracell Biotechnologies Reports Third Quarter 2023 Unaudited Financial Results and Provides Corporate Update
2023-11-08 08:30U:GRCLNews ReleaseGracell Biotechnologies Wins Overall Immunology Solution of the Year by BioTech Breakthrough Awards Program
2023-11-02 09:00U:GRCLNews ReleaseGracell Biotechnologies to Present Updated Results from BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 65 ¡ µ — Š ° American Society of Hematology Annual Meeting & Exposition
2023-11-01 16:00U:GRCLNews ReleaseGracell Biotechnologies to Participate in Four Upcoming Investor Conferences
2023-10-31 09:00U:GRCLNews ReleaseGracell Biotechnologies to Present Data Highlighting Preclinical Efficacy of SMART CART ¢ „ ¢ Against Solid Tumors at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
2023-10-30 08:30U:GRCLNews ReleaseGracell Biotechnologies to Report Third Quarter 2023 Financials on Monday, November 13, 2023